Skip to content

Comment on Toshiba device tests cancer types from a drop of bloodparent

Comments

This is true for any medical act you perform on a massive scale really. Including vaccination, supplementation, etc. Everything is a cost/benefit ratio.

Yes, and this math has been done on many of those interventions (certainly for vaccination) and the benefit holds up. That statistical base rates are problematic for cancer detection is a pretty well-understood problem.

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.